NDC product
Memantine Hydrochloride
NDC 13925-540 · Seton Pharmaceuticals
Key facts
| Product NDC | 13925-540 |
|---|---|
| Proprietary name | Memantine Hydrochloride |
| Nonproprietary name | Memantine Hydrochloride Oral |
| Substances | MEMANTINE HYDROCHLORIDE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Seton Pharmaceuticals |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA210319 |
| Pharmacologic classes | N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA] |
| Marketing start | Aug 31, 2020 |
| Marketing end | Mar 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory